Category: Vaccine
China’s first mRNA coronavirus vaccine ready for final stage trials overseas
China’s first domestically developed mRNA vaccine is ready to start its final stage trials overseas next month.The
Coronavirus pandemic – are the adenovirus vaccines finished?
Stunning developments today in relation to the adenovirus vaccines now being marketed for Covid-19, including AstraZeneca’s Vaxevria, and the Johnson and Johnson Covid-19 vaccine. More...
Canada: first blood clot case in AstraZeneca coronavirus vaccine recipient reported
Canada announced on Tuesday its first report of a rare blood clot in a person who had received the AstraZeneca COVID-19 vaccine. More...
Australia: second likely AstraZeneca coronavirus vaccine blood clot case
The second case of rare blood clots linked to the AstraZeneca COVID-19 vaccine has been detected in a woman vaccinated in Western Australia. More...
Boris Johnson: “many more people will lose loved ones to coronavirus”
12th March 2020 – Boris Johnson: “many more people will lose loved ones to coronavirus” (Guardian). More...
US health authorities call for a pause in the use of the Johnson & Johnson coronavirus vaccine after reports of blood clotting
The Food and Drug Administration (FDA) said six cases in 6.8 million doses had been reported and it was acting “out of an abundance of caution”.
Glucocorticoids and B cell depleting agents substantially impair immunogenicity of mRNA vaccines to SARS-CoV-2 coronavirus
Compared to immunocompetent controls, a three-fold reduction in anti-S IgG titers (P=0.009) and SARS-CoV-2 neutralization (p<0.0001) were observed in CID patients.
Illinois: Nearly 600 coronavirus vaccine breakthrough cases reported
More than 580 Illinoisans have tested positive for COVID-19 despite being fully vaccinated. More...
CDC: Moderna’s COVID-19 coronavirus vaccine could lead to more side effects than Pfizer/BioNTech’s
New research from the U.S. Centers for Disease Control and Prevention suggests that people who receive Moderna’s COVID-19 vaccine might experience more side effects than those who get Pfizer/BioNTech’s vaccine. More...
SARS-CoV-2 coronavirus variants B.1.351 and P.1 escape from neutralizing antibodies
“In contrast, entry of the B.1.351 and P.1 variant was partially (Casirivimab) or fully (Bamlanivimab) resistant to antibodies used for COVID-19 treatment. More...